Principal Investigator
Ashish Shah
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231234
Clinical Trial Summary
A Biomarker-Guided Phase 2 Study of DB107-RRV (a Retroviral Replicating Vector) Combined with DB107-FC (Flucytosine Extended-Release Tablets) in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Neurological Cancer
Contact Information
Phone Number
305-243-2647